2015 NCCN Nursing Program: Advancing Oncology Nursing

Hollywood, FL US
March 11, 2015

The NCCN 2015 Oncology Nursing Program at the NCCN 20th Annual Conference will provide oncology nurses with comprehensive and clinically relevant information to optimize patient education and care. Information is focused on current and critical issues to provide oncology nurses with practical information that can be implemented in the practice setting. The program agenda includes the following topics: healthy lifestyles survivorship update, current approaches to fertility preservation, management of adverse events associated with immunotherapies, and optimizing nursing care during end of life, additionally, there will be two (2) sessions with simultaneous programs focusing on hepatobiliary cancers, chronic lymphocytic leukemia/small lymphocytic lymphoma, chronic myelogenous leukemia and brain tumors.

Target Audience

This program is designed to meet the educational needs of oncology nurses who manage patients with cancer.

Learning Objectives

Following this activity, participants should be able to:

Survivorship Update: Healthy Lifestyles

  • Describe the components of a healthy lifestyle
  • Discuss the types of support that nurses can provide to help patients initiate change to a healthy lifestyle
  • Identify factors that may influence the recommendation of a specific exercise program

Current Approaches to Fertility Preservation

  • Explain factors that put patients at risk for infertility from cancer treatment
  • Describe options for male and female patients to preserve fertility before treatment
  • Discuss strategies to help nurses discuss fertility preservation with their patients

Clinical Updates and Issues: Hepatobiliary Cancers

  • List the cancers inclusive to hepatobiliary cancers
  • Explain the complexities in treating these cancers
  • Identify some of the emerging therapies in the treatment of hepatobiliary cancers

Clinical Updates and Issues: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

  • List the four recently approved drugs for the treatment of patients with CLL
  • Outline criteria that determine the clinical course of treatment
  • Discuss the adverse events that may occur with the treatment of CLL

Clinical Updates and Issues: Chronic Myelogenous Leukemia

  • List the different TKIs available and their preferred use in chronic, accelerated and blast phase CML
  • Assess barriers that impede adherence to oral TKI dose regimens
  • Distinguish common adverse events associated with TKIs

Clinical Updates and Issues: Brain Tumors

  • List at least four types of brain tumors and associated prognosis
  • Discuss new therapies in the treatment of brain tumors
  • Outline the symptom assessment and supportive care strategies for patients with brain tumors

Management of Adverse Events associated with Immunotherapies in Melanoma

  • List different types of immunotherapies and provide examples for each type
  • Describe the types of adverse events seen with immunotherapies and compare with traditional therapies
  • Identify ways in which clinical staff can improve both the implementation of these therapies and ultimately patient care

Optimizing Nursing Care during End of Life

  • List pharmacologic and non-pharmacologic interventions that may reduce pain and distress during end of life care
  • Discuss the importance of educating the family and the patient about the physiologic process of dying
  • Identify the components of the CARES tool
Additional information
Supporters: 

Supported by educational grants from:

  • Bristol-Myers Squibb
  • BTG
  • Genentech BioOncology
  • Gilead Sciences Inc.
  • Merck
  • Novartis Oncology
  • Novocure
  • Pfizer

Supported by an educational donation provided by Amgen

This program is supported by a grant from AstraZeneca.

This list of supporters was last updated on March 2, 2015.

Support is solicited from a broad array of managed care and pharma/biotech companies and organizations. This list will be updated as additional supporters are confirmed. The National Comprehensive Cancer Network® (NCCN®) appreciates that supporting companies recognize NCCN®’s need for autonomy in the development of the content of NCCN® resources. All NCCN Content is produced completely independently.

Course summary
Available credit: 
  • 5.46 Participation
  • 5.46 Nurse
Course opens: 
03/09/2015
Course expires: 
05/09/2017
Event starts: 
03/11/2015 - 8:00am
Event ends: 
03/11/2015 - 3:00pm
Cost:
$0.00
The Diplomat
3555 South Ocean Drive
Hollywood, FL 33019
United States

Available Credit

  • 5.46 Participation
  • 5.46 Nurse

Accreditation Period

Course opens: 
03/09/2015
Course expires: 
05/09/2017

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection and sound playback capability
  • Adobe Reader or other PDF reader software for certificate viewing/printing